EAGLE PHARMACEUTICALS, INC. Annual Return On Assets in % from 2015 to 2022

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Eagle Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from 2015 to 2022.
  • Eagle Pharmaceuticals, Inc. Return On Assets for the quarter ending June 30, 2023 was 2.97 %, a 60.6% decline year-over-year.
  • Eagle Pharmaceuticals, Inc. annual Return On Assets for 2022 was 9.54 %.
  • Eagle Pharmaceuticals, Inc. annual Return On Assets for 2021 was -3.34 %, a 178% decline from 2020.
  • Eagle Pharmaceuticals, Inc. annual Return On Assets for 2020 was 4.28 %, a 22.7% decline from 2019.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 9.54 +12.9 Jan 1, 2022 Dec 31, 2022
2021 -3.34 -7.62 -178% Jan 1, 2021 Dec 31, 2021
2020 4.28 -1.26 -22.7% Jan 1, 2020 Dec 31, 2020
2019 5.54 -6.84 -55.2% Jan 1, 2019 Dec 31, 2019
2018 12.4 -8.78 -41.5% Jan 1, 2018 Dec 31, 2018
2017 21.2 -29.8 -58.5% Jan 1, 2017 Dec 31, 2017
2016 51 +48.9 +2367% Jan 1, 2016 Dec 31, 2016
2015 2.07 Jan 1, 2015 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.